by DJ Edgerton (@wiltonbound)
The question seems almost nonsensical at first – your Twitter followers may be really outstanding people, but they’re not organic chemists or researchers. And your Facebook fans, while devoted, probably do not, generally speaking, know how to move a new drug through the FDA approval process.
Just the same, it’s a mistake to [...]
Tags:Compliance·data·digital strategy·Digital Tools·Education·engagement·epatient·FDA·information·innovation·Legal Issues·marketing·Pharma·Pharmaceutical industry·R&D·research and development·social media·Social network·strategy·technology·Trends·user needs
by Briana Campbell (@MsMatchGirl)
“If it’s not mobile, it won’t work in 2012 and beyond,” Jason Falls is quoted as saying in Awareness Networks 2012 Social Marketing and New Media Predictions. “We’re a marketplace conditioned to look down on our screen first. It’s not a B2C vs. B2B thing. If your users are people, you’re going [...]
Tags:BDI·case studies·Conferences·Education·events·innovation·mhealth·mobile·mobile apps·mobile healthcare·Pharma·Pharma industry·Pharmaceutical industry·roundtables·technology·Trends·User Experience·user needs
by Briana Campbell (@MsMatchGirl)
We’ve spent a lot of this year (and last) talking about how pharma is running scared of social media. And we’ve spent some time telling them to just suck it up and do it anyway. And we’ve spent a bunch of time (two years, at least!) talking about how we’re waiting for [...]
Tags:Communities·epatient·patient bloggers·patient communities·Pharma·Pharmaceutical industry·Roche Diabetes·Roche Pharmaceutical·social media·social media strategy·social networks
by Briana Campbell (@MsMatchGirl)
People like to make out that the issues surrounding pharma’s involvement with social media are extraordinarily complex. I’m not so sure.
It’s over-simplistic – but still true – to say that the main worry with digital media for the pharmaceutical industry is the interactivity of social networks. You see, I don’t think it’s [...]
Tags:Compliance·DTC·Facebook·HIPPAA·marketing·off-label·Pharma·Pharma industry·Pharmaceutical industry·reporting·social media·Social network·Twitter
by Jason Brandt (@jasondmg3)
For over half a century, the Breathalyzer has given law-enforcement officials a portable, fairly reliable instrument to test for, and prevent, driving under the influence.
However, when you start to listen to the critics of the technology complain that diabetics, dieters, hyperventilaters, mouthwash users, cold medicine users or smokers can have incorrect results [...]
Tags:analyze·breathalyzers·data·Digital Tools·future·patient·Patients·Pharma·Pharmaceutical industry·technology·Trends·User Experience·user needs
by Russ Ward (@russcward)
What does it feel like to have a heart attack? What’s the cure for muscle soreness post-workout? What one daily habit has the most positive effect on your health?
These are real questions asked on the popular question and answer site Quora. Question sites such as Quora, Yahoo! Answers, and Fluther are proliferating [...]
Tags:Compliance·crowdsource·digital strategy·Digital Tools·Education·healthcare·metrics·Patients·Pharma·Pharmaceutical industry·regulations·social media metrics
by Sven Larsen
#Adaptordie is an apt hashtag to sum up the teachings of digital-media pundit Brian Solis. It’s also an apt hashtag to describe the current state of affairs in the pharmaceutical industry.
Solis’s new book, The End of Business as Usual, a follow-up to the popular Engage, focuses on this need of business to change the old ways and [...]
Tags:digital strategy·Digital Tools·Facebook·FDA·healthcare·innovation·marketing·Pharma·Pharmaceutical industry·social media·social networks·Trends
by DJ Edgerton (@wiltonbound)
How much of a role does social media play in influencing policymakers? And how much of a role can – or should – marketing play in crafting those messages for pharmaceutical companies?
It’s a tough question, but before we get to it, take a moment to listen carefully. Hear that high-pitched, faint screaming [...]
Tags:communications·elected officials·Facebook·FDA·patient needs·Pharma·Pharmaceutical industry·politics·social media·social networks·Twitter
This post is part of a series of point/counterpoint arguments proposed by different members of the Pixels & Pills staff. We’re strong believers that healthy arguments can yield the best solutions, and we hope that you enjoy our series. Feel free to add your own arguments in the comments section below!
by Jason Brandt (@jasondmg3)
Yesterday you [...]
Tags:doctor·doctor's office·doctors practice·Education·epatient·healthcare·information·patient·Pharmaceutical industry·technology·Trends
This post is part of a series of point/counterpoint arguments proposed by different members of the Pixels & Pills staff. We’re strong believers that healthy arguments can yield the best solutions, and we hope that you enjoy our series. Feel free to add your own arguments in the comments section below!
by Krissy Goelz (@krisgoelz)
I’m not [...]
Tags:doctor·doctor's office·doctors practice·Education·epatient·healthcare·information·patient·Pharmaceutical industry·technology·Trends
